us approves second new hepatitis c drug
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

US approves second new hepatitis C drug

Arab Today, arab today

Arab Today, arab today US approves second new hepatitis C drug

WASHINGTON - AFP

The US Food and Drug Administration on Monday approved Incivek to treat hepatitis C when taken along with the current two-drug regimen, marking the second such drug approval this month. "The sustained virologic response for patients treated with Incivek across all studies, and across all patient groups, was between 20 and 45 percent higher than current standard of care," the FDA said. Incivek is a pill that should be taken three times a day with food, and is added to therapy made up of peginterferon alfa and ribavirin. In mid-May, the US regulatory agency approved a Merck-made pharmaceutical known as Victrelis. Both have been shown to boost cure rates when added to the present regimen, which helps fewer than 50 percent of people with the liver disease. The existing two-drug treatment of pegylated interferon and ribavirin for genotype 1 chronic hepatitis C was approved by US regulators in 1998. "With the approval of Incivek, there are now two important new treatment options for hepatitis C that offer a greater chance at a cure for some patients with this serious condition," said Edward Cox, director of the office of antimicrobial products in FDA's Center for Drug Evaluation and Research. "The availability of new therapies that significantly increase responses while potentially decreasing the overall duration of treatment is a major step forward in the battle against chronic hepatitis C infection." Incivek, or telaprevir, is marketed by the Massachusetts-based Vertex Pharmaceuticals.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

us approves second new hepatitis c drug us approves second new hepatitis c drug

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

us approves second new hepatitis c drug us approves second new hepatitis c drug

 



GMT 12:59 2017 Thursday ,14 December

Oil prices fall on rising US output

GMT 12:59 2017 Wednesday ,12 April

Waleed Tawfiq Cancels his concert in Egypt

GMT 08:18 2017 Thursday ,04 May

Algerians vote amid anger over economy

GMT 22:12 2017 Thursday ,30 November

Al Jazira Club signs MoU with Orange Sports Forum

GMT 07:18 2017 Saturday ,11 February

Trump welcomes Abe with warm White House embrace

GMT 22:57 2017 Tuesday ,10 October

Italy train crash probe looking into antiquated al

GMT 11:04 2017 Wednesday ,15 November

Tamim blames neighboring states for current Gulf crisis

GMT 05:11 2017 Tuesday ,17 October

Three killed, 360,000 without power

GMT 08:47 2016 Wednesday ,09 November

'Zika can break out anywhere,' warns Brazilian doctor

GMT 05:43 2017 Thursday ,12 October

Dubai Islamic Bank third-quarter profit up 26%
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday